Major projects in this area include:

Identification of biomarkers for pre-malignant lesions in gastrointestinal cancers

This research will lead to potential earlier/improved early diagnosis and tailored management/treatment.

Barrett’s oesophagus (pre-malignant lesion) and Oesophageal cancer)
Investigators: Prof David Watson, Dr Damian Hussey and others.
Further information: Dr Damian Hussey

Adenomas (pre-malignant lesion) and Colorectal cancer
Investigators: Prof Graeme Young, Dr Michael Michael, Dr Rob James and others.
Further information: Prof Graeme Young

microRNAs in control of cancer development and progression

Potential cancer markers or therapeutics (all cancer types).
Investigator: Dr Michael Michael
Further information: Dr Michael Michael

New and improved cancer diagnostic tools

Development of diagnostic tools that incorporate gene-based tests together with histopathology, imaging and flow cytometry. This includes:

  • tests for ‘residual disease’, esp haematological malignancies (leukaemia and lymphoma) that monitor cancer treatment, detect relapses and allow tailored treatment (Prof Alec Morley and others);
  • the only integrated lymphoma diagnostics service in Australia (Dr Bryone Kuss)

Investigators: A/Prof Pam Sykes, Dr Bryone Kuss, Dr Scott Grist, Prof Alec Morley and others.
Further information: Dr Bryone Kuss